Press release
Codex Labs Introduces First Bia OTC: Eczema Relief Lotion
SAN JOSE, CA - Feb 25th, 2025 - Codex Labs (https://www.codexlabscorp.com/), a Silicon Valley skintech company, has launched the first of its Bia over-the-counter (OTC) topicals for eczema management. Bia, meaning "food" in Gaelic, is often paired with "nourishment" in Celtic philosophy.The BIA eczema lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses hydration, skin barrier repair (both increased ceramide and structural protein production), and itch reduction in distinct yet synergistically-effective ways.
"At Codex Labs, we are excited to expand the clinical effectiveness of our plant-biotech-based skincare solutions to addressing itch and dryness symptoms associated with atopic dermatitis, or eczema," stated Dr. Barbara Paldus, CEO and Founder of Codex Labs. "By doing so, we have further demonstrated our commitment to bringing much-needed relief to people suffering from inflammation-based skin conditions."
The OTC Eczema Relief Lotion was designed to be used in conjunction with the Bia Unscented Soap, the first vegan, MyMicrobiome-certified soap launched in 2021. The combination, called "Eczema Essentials," delivers skin hydration, moisture retention, skin barrier repair, and relief from itching.
"The Eczema Essentials set was tested in a clinical study and performed well for managing mild to moderate eczema. It is remarkable to think that these are over-the-counter products, available to everyone without a prescription," stated Dr. Peter Lio, a leading US expert in pediatric eczema and Codex Labs Medical Advisory Board member.
The Eczema Essentials set was also combined with the Antu Skin Barrier Support supplement in a trio called "Ditch the Itch." The addition of the Antu supplement provides l-histidine, an amino acid used by the body for filaggrin protein and natural moisturizing factor production, as well as a novel antioxidant from Patagonia (M3 Trademark ) that helps address internal inflammation by combatting free radicals production and lipid peroxidation.
This topical-ingestible "Ditch the Itch" trio underwent a clinical trial on subjects having mild to moderate eczema (SCORAD = 34.5). The measured improvement in 8 weeks included:
*
93% reduction in eczema score (SCORAD) in 100% of subjects
*
88% reduction of itch in 97% of subjects
*
117% hydration increase in 91% of subjects
*
83% flakiness (desquamation) decrease in 97% of subjects
*
29% trans-epidermal water loss (TEWL) reduction in 79% of subjects
The clinical results of this combined inside-out approach demonstrate the importance of addressing skin conditions with both topicals and ingestibles in an integrative skin-gut approach.
All three products are vegan- and cruelty-free, and the two topicals are also MyMicrobiome-certified. All Codex products are manufactured in high-tech GMP (Good Manufacturing Practice) facilities to ensure they are made to the highest quality standards. They contain sustainably optimized ingredients and are filled in renewable, sugarcane green PE tubes, which reduces their carbon footprint by over 50%.
About Codex Labs
Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Our products are focused on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema, and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free, and sustainable dermaceutical solutions.
Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=codex-labs-introduces-first-bia-otc-eczema-relief-lotion]
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Codex Labs Introduces First Bia OTC: Eczema Relief Lotion here
News-ID: 3885988 • Views: …
More Releases from ABNewswire

Down Syndrome Market Poised for Transformation with Advancing Genetic Research a …
Down Syndrome, caused by an extra copy of chromosome 21, is one of the most common chromosomal disorders, marked by intellectual disability, developmental delays, and health issues like heart defects and thyroid problems. Advances in prenatal screening and supportive care are improving management and outcomes.
DelveInsight's "Down Syndrome Market Report [https://www.delveinsight.com/report-store/down-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" offers a robust analysis of epidemiological trends, patient segmentation, and disease burden across key geographies, including the United States, EU5…

Dilated Cardiomyopathy Market Expected to Grow Amid Advancements in Targeted The …
Dilated Cardiomyopathy (DCM) is a progressive heart condition marked by enlarged, weakened ventricles, reducing cardiac output and potentially leading to heart failure. It can be idiopathic or caused by genetics, infections, autoimmune diseases, or toxins, and poses serious risks, especially in younger and pediatric patients.
DelveInsight's "Dilated Cardiomyopathy Market Report [https://www.delveinsight.com/report-store/dilated-cardiomyopathy-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" delivers an in-depth analysis of the evolving DCM landscape, including historical and projected epidemiological data across major geographies such as…

Dermatomyositis Market Set to Advance with Improved Diagnosis and Emerging Immun …
Dermatomyositis is a rare, chronic, inflammatory myopathy characterized by progressive muscle weakness and distinctive skin rashes, often associated with autoimmune mechanisms. It can occur in both adults and children and may involve complications such as interstitial lung disease, malignancy, and calcinosis. Despite its rarity, dermatomyositis remains a significant clinical concern due to its multisystem involvement, diagnostic complexity, and limited treatment options.
DelveInsight's "Dermatomyositis Market Insight, Epidemiology, and Market Forecast - 2034…

Gene Therapy in Ophthalmology Market Set to Transform Vision Restoration Landsca …
Gene therapy is rapidly emerging as a game-changer in the field of ophthalmology, offering new hope for patients with inherited retinal disorders and other sight-threatening conditions. As conventional treatments often fail to address the underlying genetic causes, gene therapies aim to correct or replace faulty genes, offering long-term or even curative outcomes. DelveInsight's latest report explores how this cutting-edge approach is reshaping the future of ocular disease treatment.
DelveInsight's "Gene Therapy…
More Releases for Codex
Pesticide Residue Testing Market Projected to Witness Vigorous Expansion during …
According to Stratagem Market Insights' latest sales report, Global Pesticide Residue Testing Market seems to be making great strides over the next few years. Analysts have scrutinized the market drivers, constraints, risks and openness that exist throughout the market. The Pesticide Residue Testing report shows the processes and estimates that the market expects in the coming years. Careful research aims to understand the flow of the market. Through competitive environment…
Pesticide Residue Testing Market To See Huge Growth, Industry Research Technolog …
The "Pesticide Residue Testing Market" report provides exhaustive information on the different business characteristics of the industry such as approaches, models and key players working in different regions. Responsible for providing accurate and important information related to market conditions and developments, and to estimate growth factors, quantitative analysis and business processes. This report constitutes the market growth, market characteristics, and market size of the Pesticide Residue Testing industry and categorizes…
Synthetic Biology Market is gaining significant traction with August 2020, Codex …
Synthetic Biology is a wide-ranging field of research that aims to develop new organic compounds, devices, and apparatus, or to design new living systems. Synthetic Biology has opened up an entirely new chapter of biological engineering, as it has the potential to dramatically impact our culture and our economy. Over the years, synthetic biology has become an important subject of exploration and study as it holds the potential to develop…
Codex Mysterium unique & eccentric puzzle book now live on Kickstarter
Innovario is excited to announce the launch of a Kickstarter campaign for Codex Mysterium; an immersive and richly illustrated puzzle book, filled with a diverse mix of unique and interrelated brain teasers, riddles and conundrums. It features many one-of-a-kind puzzles designed specifically for this book as well as unconventional twists on well-known puzzle types.
Codex Mysterium is a stand-alone sequel to the successful Codex Engimatum puzzle book. Rami Hansenne, the author,…
Enzymes Market 2025 | Chr. Hansen, Novozymes A/S, Codex is Inc., Novus Internati …
Enzymes are biocatalysts, which accelerate various biochemical reactions. In the current scenario, enzymes serve as useful biocatalysts for several industrial processes and chemical reactions Moreover, they play an important role in chemical engineering, food technology, and agriculture. Enzymes have gained a substantial market share in the recent years, due to high adoption of enzymes based pharmaceuticals required for the treatment of several chronic disorders and digestive diseases
Carbohydrates type is estimated…
Enzymes Market 2025 | Chr. Hansen, Novozymes A/S, Codex is Inc., Novus Internati …
Enzymes are biocatalysts, which accelerate various biochemical reactions. In the current scenario, enzymes serve as useful biocatalysts for several industrial processes and chemical reactions Moreover, they play an important role in chemical engineering, food technology, and agriculture. Enzymes have gained a substantial market share in the recent years, due to high adoption of enzymes based pharmaceuticals required for the treatment of several chronic disorders and digestive diseases
Carbohydrates type is estimated…